A secondary stock sale and underwhelming quarterly results sent investors to the off-ramp.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...
The pharmaceutical company's growth prospects have taken a big hit.
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Sage...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...
The company got bad news from the FDA and saw increased losses.
These companies aren't bargains at all.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...
A regulatory setback weighed heavily on the drugmaker's shares Monday.
Stocks that traded heavily or had substantial price changes on Monday: Sovos Brands, Elanco Animal Health rise; Tyson Foods, Gogo fall